These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 8567042

  • 1. Does the renin-angiotensin system determine the renal and systemic hemodynamic response to sodium in patients with essential hypertension?
    van Paassen P, de Zeeuw D, Navis G, de Jong PE.
    Hypertension; 1996 Feb; 27(2):202-8. PubMed ID: 8567042
    [Abstract] [Full Text] [Related]

  • 2. Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension.
    van Paassen P, de Zeeuw D, de Jong PE.
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):39-45. PubMed ID: 7564363
    [Abstract] [Full Text] [Related]

  • 3. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
    Visser FW, Boonstra AH, Titia Lely A, Boomsma F, Navis G.
    Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment renal vascular tone predicts the effect of specific renin inhibition on natriuresis in essential hypertension.
    van Paassen P, Navis GJ, De Jong PE, De Zeeuw D.
    Eur J Clin Invest; 1999 Dec; 29(12):1019-26. PubMed ID: 10583449
    [Abstract] [Full Text] [Related]

  • 5. Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function.
    van Paassen P, de Zeeuw D, Navis G, de Jong PE.
    Nephrol Dial Transplant; 2000 May; 15(5):637-43. PubMed ID: 10809804
    [Abstract] [Full Text] [Related]

  • 6. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
    Azizi M, Guyene TT, Chatellier G, Ménard J.
    J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
    [Abstract] [Full Text] [Related]

  • 7. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.
    Circulation; 2008 Jun 24; 117(25):3199-205. PubMed ID: 18559696
    [Abstract] [Full Text] [Related]

  • 8. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R, Nolly H, Giannone C, Baglivo HP, Ramírez AJ.
    J Hypertens; 2003 Feb 24; 21(2):411-7. PubMed ID: 12569273
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.
    Parfrey PS, Markandu ND, Roulston JE, Jones BE, Jones JC, MacGregor GA.
    Br Med J (Clin Res Ed); 1981 Jul 11; 283(6284):94-7. PubMed ID: 6789950
    [Abstract] [Full Text] [Related]

  • 11. Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake.
    Lopes de Faria JB, Friedman R, de Cosmo S, Dodds RA, Mortton JJ, Viberti GC.
    Nephron; 1997 Jul 11; 76(4):411-7. PubMed ID: 9274838
    [Abstract] [Full Text] [Related]

  • 12. Renal hemodynamic response to an angiotensin II antagonist, eprosartan, in healthy men.
    Price DA, De'Oliveira JM, Fisher ND, Hollenberg NK.
    Hypertension; 1997 Aug 11; 30(2 Pt 1):240-6. PubMed ID: 9260987
    [Abstract] [Full Text] [Related]

  • 13. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J, Rabinowe S, Hollenberg NK, Williams GH.
    J Clin Invest; 1985 Apr 11; 75(4):1285-90. PubMed ID: 2985655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Renin inhibition improves pressure natriuresis in essential hypertension.
    Paassen PV, Zeeuw D, Jong PE, Navis G.
    J Am Soc Nephrol; 2000 Oct 11; 11(10):1813-1818. PubMed ID: 11004211
    [Abstract] [Full Text] [Related]

  • 16. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
    Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, Schmieder RE.
    J Hypertens; 2002 Jan 11; 20(1):117-24. PubMed ID: 11791034
    [Abstract] [Full Text] [Related]

  • 17. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED, Bader BD, Rüb N, Rauscher MA, Rebenschütz I, Gaber OC, Enderle MD, Risler T, Erley CM.
    Kidney Blood Press Res; 2002 Jan 11; 25(1):42-9. PubMed ID: 11834876
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin-(1-7)-induced renal vasodilation in hypertensive humans is attenuated by low sodium intake and angiotensin II co-infusion.
    van Twist DJ, Houben AJ, de Haan MW, Mostard GJ, Kroon AA, de Leeuw PW.
    Hypertension; 2013 Oct 11; 62(4):789-93. PubMed ID: 23918750
    [Abstract] [Full Text] [Related]

  • 19. Relation between the renin-angiotensin-aldosterone system and left ventricular structure and function in young normotensive and mildly hypertensive subjects.
    Schlaich MP, Klingbeil A, Hilgers K, Schobel HP, Schmieder RE.
    Am Heart J; 1999 Nov 11; 138(5 Pt 1):810-7. PubMed ID: 10539810
    [Abstract] [Full Text] [Related]

  • 20. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W, Linder L, Kleinbloesem C, van Brummelen P, Bühler FR.
    Circulation; 1992 Jan 11; 85(1):1-8. PubMed ID: 1728438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.